Try using green tea extract to treat blood cancer

Researchers at the Mayo Hospital (USA) reported on the clinical trial of the active ingredient of epigallocatechin galat green tea (EGCG) to treat leukemia (leukemia) in the early stages and obtained positive results.

Can green tea extracts become future blood cancer drugs?
(Photo: Internet).

Tests determined that patients with chronic lymphoma (chronic lymphocytic leukemia, CLL) can tolerate this substance in high doses prepared in capsule form. As a result, the number of lymphocytes has decreased by one third in patients taking the test.

Dr Tait Shanafelt, a hematologist from Mayo Hospital, who chaired the study, said: " We have found that not only patients with high doses of green tea extract, many patients still have it. a significant degree of reversal of CLL disease Most patients at the beginning of the study had enlarged lymph nodes, in more than 50% of patients, the size of the lymph nodes decreased . '

CLL is the most common form of blood cancer in the United States. Currently this disease has no cure. However, it can be diagnosed early by blood test and then monitored until the disease develops to confirm. The statistics show that right from the beginning, the disease was in a state of severe CKK and died quite quickly. Researchers hope that EGCG can stabilize CLL at an early age and enhance treatment efficacy when combined with other treatments.

The study, which has now moved to the second stage, is a clinical trial with the same patients, who have been able to tolerate the highest doses when taking the previous test.

These clinical studies are the last step of the topic that lasts many years. starting with the trial of extract of green tea on cancer cells at Hematology Laboratory Meil ​​Kay, a co-author of the study. After confirming the high efficiency of killing cancerous white blood cells, the invention was tested on animal cells and eventually on human cells in the laboratory.

In the first clinical trial, 33 patients participated in 8 groups with different dosages administered orally with Polyphenom E, the extract with the main ingredient being EGCG. The dosage is 400 to 2000 mg twice daily. The trial has not ended but the results are very positive.